blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3303365

EP3303365 - PRODRUGS COMPRISING A PYROGLUTAMATE LINKER [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  02.10.2020
Database last updated on 18.11.2024
FormerRequest for examination was made
Status updated on  09.03.2018
FormerThe international publication has been made
Status updated on  09.12.2016
Most recent event   Tooltip01.06.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Ascendis Pharma Inc.
510 Waverley Street
Palo Alto, CA 94301 / US
For all designated states
Ascendis Pharma A/S
Tuborg Boulevard 12
2900 Hellerup / DK
[2018/15]
Inventor(s)01 / RAU, Harald
Talstrasse 41i
69221 Dossenheim / DE
02 / BISEK, Nicola
Dantestrasse 50
69115 Heidelberg / DE
03 / WEISBROD, Samuel
Husarenstrasse 8
69121 Heidelburg / DE
 [2018/15]
Representative(s)Büchel, Edwin
Patentanwälte
Isenbruck Bösl Hörschler PartG mbB
Eastsite One
Seckenheimer Landstraße 4
68163 Mannheim / DE
[N/P]
Former [2018/15]Büchel, Edwin
Isenbruck Bösl Hörschler LLP Patentanwälte Eastsite One Seckenheimer Landstraße 4
68163 Mannheim / DE
Application number, filing date16804033.525.05.2016
[2018/15]
WO2016US34105
Priority number, dateEP2015016984329.05.2015         Original published format: EP 15169843
[2018/15]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2016196124
Date:08.12.2016
Language:EN
[2016/49]
Type: A2 Application without search report 
No.:EP3303365
Date:11.04.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 08.12.2016 takes the place of the publication of the European patent application.
[2018/15]
Search report(s)International search report - published on:US19.01.2017
(Supplementary) European search report - dispatched on:EP21.03.2019
ClassificationIPC:A61K47/60
[2019/04]
CPC:
A61K47/60 (EP,US); A61K47/645 (US); A61K47/54 (EP,US)
Former IPC [2018/15]C07K4/00, C07K5/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/15]
TitleGerman:PRODRUGS MIT EINEM PYROGLUTAMAT-LINKER[2018/15]
English:PRODRUGS COMPRISING A PYROGLUTAMATE LINKER[2018/15]
French:PROMÉDICAMENTS COMPRENANT UN LIEUR DE PYROGLUTAMATE[2018/15]
Entry into regional phase19.12.2017National basic fee paid 
19.12.2017Search fee paid 
19.12.2017Designation fee(s) paid 
19.12.2017Examination fee paid 
Examination procedure19.12.2017Examination requested  [2018/15]
19.12.2017Date on which the examining division has become responsible
17.10.2019Amendment by applicant (claims and/or description)
06.10.2020Despatch of a communication from the examining division (Time limit: M04)
16.12.2020Reply to a communication from the examining division
27.09.2023Despatch of a communication from the examining division (Time limit: M04)
06.02.2024Reply to a communication from the examining division
Fees paidRenewal fee
28.05.2018Renewal fee patent year 03
29.05.2019Renewal fee patent year 04
20.03.2020Renewal fee patent year 05
28.05.2021Renewal fee patent year 06
30.03.2022Renewal fee patent year 07
24.03.2023Renewal fee patent year 08
31.05.2024Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US2013072491  (YASUDA REIKO [JP], et al) [X] 1,3,13,15 * page 32; table 3; compound 22 * * tables 2, 3 *;
 [XI]US2014323402  (HERSEL ULRICH [DE], et al) [X] 1,3,13,15 * paragraphs [0766] , [ 768] *[I] 1-15;
 [X]WO2015006740  (ALNYLAM PHARMACEUTICALS INC [US]) [X] 1,3,13,15 * claim 1; compounds 1644573-46-5or RN 1644573-31-8 *;
 [X]  - GOLDSTEIN ALEX S ET AL, "Testosterone delivery using glutamide-based complex high axial ratio microstructures", BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON, GB, (20010611), vol. 9, no. 11, doi:10.1016/S0968-0896(01)00149-3, ISSN 0968-0896, pages 2819 - 2825, XP085061058 [X] 1-3,12-15 * sheme 2, figure 4 * * the whole document *

DOI:   http://dx.doi.org/10.1016/S0968-0896(01)00149-3
International search[X]US2013072491  (YASUDA REIKO [JP], et al) [X] 1, 2 * entire document *;
 [A]US2014323402  (HERSEL ULRICH [DE], et al) [A] 1, 2 * entire document *;
 [A]  - PUBCHEM, (20140820), Database accession no. 651631, XP055437933 [A] 1, 2 * . entire document *
by applicantWO03024047
 WO2005099768
 WO2006003014
 WO2006136586
 WO2009095479
 WO2011012722
 WO2011012715
 WO2011089214
 WO2011089216
 WO2011089215
 WO2013024049
 WO2013024047
 WO2014056926
 US2014323402
    - GUDE, Letters in Peptide Science, (20020000), vol. 9, no. 4, pages 203 - 206
 EP20150169843
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.